ArticleNature2024
Clonal dynamics after allogeneic haematopoietic cell transplantation.
Abstract read
In one paragraph
Article in Nature, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.
0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed.
- Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis After Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025Trial
- Clonal Dynamics After Allogeneic Hematopoietic Stem Cell Transplantation from Related Donors: A Case Series.International journal of molecular sciences · 2026Article
- A single-cell lens into the co-evolution of genotypes and phenotypes in cancer.Nature reviews. Cancer · 2026Review
- The Evolution of Polyclonal Competition in Aging Hematopoiesis.Cancer discovery · 2026Article
- Ex vivo expansion of hematopoietic stem and progenitor cells from human mobilized peripheral blood for gene therapy applications.Molecular therapy : the journal of the American Society of Gene Therapy · 2026Article
- Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies.Transfusion · 2026Review
- Clonal memory of cell division in humans diverges between healthy haematopoiesis and acute myeloid leukaemia.Nature communications · 2026Article
- Clonal hematopoiesis in patients with cancer and cancer survivors: From clonal burden to cardiovascular diseases.Cancer · 2026Review
- Clinical decisions in clonal hematopoiesis: a contemporary review for clinicians.Haematologica · 2026Review
- Metabolite-induced DNA damage drives stochastic stem cell loss and clonal hematopoiesis.Cell stem cell · 2026Article
- Review
- Human TET2-Mutant Clonal Hematopoiesis Expansion Is Driven by Distinct Inflammatory Signaling Responses in Stem Cells Versus Myeloid Progeny.Blood cancer discovery · 2026Article
- From Selection to Use: Aptamers as Targeting Reagents in Hematology.Biomedicines · 2026Review
- Modeling mitochondrial inheritance enables high-precision single-cell lineage tracing in humans.bioRxiv : the preprint server for biology · 2026Article
- Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.Journal of clinical medicine · 2026Review
- Hematopoietic stem cell aging promotesResearch square · 2026Article
- Molecular and phenotypic blueprint of human hematopoiesis links proliferation stress to stem cell aging.The Journal of experimental medicine · 2026Article
- T cell and monocyte activation in concert with hematopoietic stem cell interactions shapes the post-allogeneic transplant immune landscape in poor graft function.Frontiers in immunology · 2026Article
- Reconstructing the lifelong history of cells and tissues via somatic mutation analysis.Cellular and molecular life sciences : CMLS · 2025Review
- Stable, intrinsically programmed lineage restriction of human hematopoietic stem cells.Nature genetics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Michael Spencer ChapmanCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0002-5320-8193
C Matthias WilkDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-5429-7143
Steffen BoettcherDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-9937-0957
Emily MitchellCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.
Kevin DawsonCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.
Nicholas WilliamsCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0003-3989-9167
Jan MüllerDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Larisa KovtonyukDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Hyunchul JungCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.
Francisco CaiadoDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-4096-4448
Kirsty RobertsCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.
Laura O'NeillCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.
David G KentWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge, UK.ORCID 0000-0001-7871-8811
Anthony R GreenWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, Cambridge, UK.
Jyoti NangaliaCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.ORCID 0000-0001-7122-4608
Markus G ManzDepartment of Medical Oncology and Hematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland. Markus.Manz@usz.ch.ORCID 0000-0002-4676-7931
Peter J CampbellCancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK. pc8@sanger.ac.uk.ORCID 0000-0002-3921-0510
Funding
Medical Research Council MC_PC_17230Wellcome Trust
Abstract
Allogeneic haematopoietic cell transplantation (HCT) replaces the stem cells responsible for blood production with those from a donor
Indexed as
Clone CellsHematopoietic Stem CellsHematopoietic Stem Cell TransplantationTransplantation, HomologousAdolescentAdultAgedCell LineageCell MovementCell ProliferationCell SurvivalCellular SenescenceHematopoiesisHumansMaleMiddle Aged
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.